Thymocytes bearing autoreactive TCR are eliminated from the organism by a process termed negative selection. The molecular basis of this deletion has been recently shown to be a consequence of TCR-triggered activation of a caspase by certain peptide-MHC ligands in the immature CD4 ⍣ CD8 ⍣ double-positive (DP) thymocyte subpopulation. Of note, the numerically minor TCR high DP thymocyte subpopulation, unlike the major TCR low DP subset, is resistant to negative selection. Despite exposure to cognate peptide, TCR high DP thymocytes mature into single-positive thymocytes and are exported into the periphery. Here we investigated the mechanism by which these thymocytes escape negative selection. Using a cytochemical assay in conjunction with a caspase-specific affinity ligand, we demonstrate that the resistance of the TCR high DP thymocytes to negative selection correlates with the disappearance of TCR-triggered caspase activity in these cells. Thus thymocytes which have presumably begun the positive selection process inactivate the thymic caspase pathway and are no longer susceptible to negative selection.
Introduction
The stochastic process of gene rearrangement followed by association of the resulting diverse TCR α and β subunits elaborates~10 16 potential TCR specificities. The processes of positive and negative selection then preserve but a subset of those possibilities by expanding thymocytes carrying TCR specificities which are appropriately self-MHC restricted or eliminating those carrying autoreactive TCR respectively (1) (2) (3) (4) . In addition, thymocytes expressing TCR incapable of interacting with self-MHC undergo 'death by neglect'. The molecular mechanisms of positive selection and death by neglect are not understood; however, thymocytes undergoing negative selection die by apoptosis, a form of cell death used by metazoan organisms for development as well as for homeostasis (5) (6) (7) . Using normal mice or mice transgenic for TCR of known specificity, it has been shown that apoptosis in thymocytes is antigen-MHC dependent and affects the majority of immature CD4 ϩ CD8 ϩ double-positive (DP) thymocytes and a subset of immature single-positive (SP) thymocytes (8) (9) (10) (11) (12) (13) (14) .
Correspondence to: Y. Ghendler, Laboratory of Immunobiology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA Transmitting editor: T. Taniguchi Received 22 January 1998, accepted 12 February 1998 We have constructed a TCR transgenic mouse termed N15tg which recognizes a vesicular stomatitis virus octapeptide (VSV8) in the context of the murine H-2K b class I MHC molecule. This N15tg line was constructed on a RAG-2 -/-background thus limiting expression to the N15 TCR only. Injection of VSV8 peptide in vivo induces a massive increase in apoptotic cells within the ensuing 4 h, followed by depletion of CD4 ϩ CD8 ϩ DP thymocytes with attendant cortical collapse (15) . These same events occur when fetal thymic organ cultures (FTOC) from N15tg mice are treated with VSV8 peptide (15, 16) . Both the deletion of DP thymocytes and the increase in TUNEL-positive cells can be blocked in N15tg FTOC by zVADfmk, a cell permeable inhibitor of caspases (16) . These enzymes, a family of cysteine proteases, are involved in apoptosis in many cellular pathways; caspases exist as inactive proenzymes which, upon cleavage, form active heterodimers made up of~20 and~10-12 kDa subunits (17, 18) . The activated enzymes then cleave cellular substrates including other caspase family members resulting in cell death. Using biotinylated DEVDamk as an affinity ligand probe to detect active caspases by Western blot analysis, we have provided direct biochemical evidence that VSV8 treatment of N15tg mice triggers activation of a thymic caspase(s) in DP thymocytes. Thus, antigen-induced negative selection of DP thymocytes occurs by TCR-mediated activation of a caspase(s) resulting in apoptosis of those cells (16) and it has recently shown that caspase-3 participates in this process (19) .
Although VSV8 injection in vivo induces deletion of 90-95% DP thymocytes in N15tg mice, we detect a subset of TCR high DP thymocytes which selectively escapes negative selection. These TCR high DP thymocytes have a TCR identical to those DP thymocytes which die, but at a 5-to 10-fold higher surface copy number (15) . To determine the mechanism by which these TCR high DP thymocytes elude negative selection, we examined this subpopulation for inducible caspase activity upon TCR triggering by peptide-MHC using immunohistochemical analysis with biotinylated DEVDamk. We observe that while TCR low DP thymocytes express active caspase upon TCR ligation, the TCR high DP thymocytes do not. Thus the TCR high DP thymocytes no longer express a functionally active caspase and are thereby resistant to negative selection.
Methods

Animals
N15 TCR tg RAG-2 -/-H-2 b (N15tg) animals were constructed as previously described (15) . These animals express α and β TCR cDNAs isolated from the N15 CTL clone (20) . Homozygous N15 TCR tg RAG-2 -/-H-2 b mice were subsequently obtained by inter-crossing N15tg mice. To create the N15 ϩ/ ϩ RAG-2 -/-β 2 -microglobulin (β 2 M) -/-mice, the N15 ϩ/ϩ RAG-2 -/-mice were bred with β 2 M -/-mice which had been backcrossed for 10 generations into C57BL/6 (H-2 b ) (Jackson Laboratory, Bar Harbor, ME). The heterozygous mice from the first generation were inter-crossed and offspring which were RAG-2 -/-β 2 M -/-N15 ϩ/ϩ utilized. The expression of N15 TCR as well as the lack of RAG-2 or β 2 M in the knockouts were detected by FACS analysis on peripheral blood cells as described below. The homozygosity of the N15tg was proven by subsequent breeding analysis. All lines were maintained and bred under sterile barrier conditions at the animal facility of Dana-Farber Cancer Institute. For injection of peptide, 24 µg of VSV8 (RGYVYQGL) or altered peptide ligands (APL) K1 (KGY-VYQGL) and I4 (RGYIYQGL) in 250 µl PBS were injected into the tail vein of mice.
Flow cytometric analysis and cell sorting
The following mAb were used: anti-CD4 (H129.19) R-phycoerythrin (PE) labeled and anti-CD8 (53-6.7) Red613 labeled (Gibco/BRL, Grand Island, NY); anti-N15β (R53) (20) , antimouse CD45R/B220 (RA3-6B2) PE labeled (PharMingen, San Diego, CA), 5F1.1.24 (anti-mouse H-2K b ) (21) FITC labeled and goat anti-rat IgG FITC labeled (Caltag, South San Francisco, CA). Thymocytes were triple stained as follows: cells were incubated with R53 for 30 min followed by FITC conjugated goat anti-rat antibodies. After washing with PBS contain 2% FCS the cells were restained with PE-anti-CD4 and Red613-anti-CD8 mAb for an additional 30 min in PBS containing 2% FCS and 2% normal rat serum. For RAG-2 and β 2 M phenotyping, peripheral blood nucleated cells were double stained with PE-anti-mouse CD45R/B220 and FITC-5F1 for 30 min, and, before analysis, red blood cells were eliminated from peripheral blood cells by ammonium chloride lysis. Flow cytometric analysis was performed on a FACScan (Becton Dickinson, San Jose, CA). Samples were gated on live cells based on forward and side scatter parameters. Data (10,000 events per sample) were collected in list mode using FACScan Research software and analyzed using Lysys II software (Becton Dickinson). For DP TCR low and DP TCR high cell sorting of thymocytes from the N15tg mice, thymocytes were stained with PE-anti-CD4 mAb and R53 followed by goat anti-rat-FITC and then sorted twice at 4°C in RPMI 1640 ϩ 10% FCS. After the first sort for CD4-expressing cells (DP), sorted cells were centrifuged, resuspended and resorted to obtain a CD4 ϩ TCR low subpopulation (~70% of the DP fraction) and a CD4 ϩ TCR high subpopulation (~5% of the DP fraction) using a FACS Vantage cell sorter (Becton Dickinson). Immediately after sorting, aliquots from the sorted cells were double stained with PE-anti-CD4 and Red613-anti-CD8, and reanalyzed on a FACScan to confirm the purity of the sorted DP subpopulations.
Cytochemical analysis of caspase
Aliquots of 100 µl of unsorted or sorted thymocytes at 0.5-1 ϫ 10 6 cells/ml were placed on a microscope slide using a cytospin apparatus, air dried for 1 h and fixed with 100% cold acetone for 10 min. Slides were then kept at -20°C until staining. In situ caspase analysis was performed as previously described (16) . Briefly, cytosmears of thymocytes were incubated with avidin and biotin (Vector, Burlingame, CA) sequentially for blocking the endogenous biotin. After washing with PBS, the cytosmears were incubated with 0.2-0.4 mM biotin-DEVDamk peptide at room temperature for 1 h, followed by incubation with avidin-biotinylated peroxidase complex (Dako, Santa Barbara, CA) for 45 min at room temperature and washed three times with PBS. After 5 min development in a solution of 3-amino-9-ethycarbazole (Aldrich, Milwakee, WI) the reaction was stopped by dipping into distilled water. The specimens were post-fixed with 2% paraformaldehyde, counterstained with hematoxylin (Sigma, St Louis, MO) and mounted with glycergel (Dako). Pictures were taken using an objective with a ϫ40 giving a final magnification of ϫ400.
Results and discussion
DP TCR high thymocytes are resistant to cognate-peptidemediated deletion in vivo To investigate negative selection events during intrathymic ontogeny, we established TCR transgenic mice (N15tg) on a RAG-2 -/-(H-2 b ) background expressing a single TCR specific for vesicular stomatitis virus nuclear octapeptide N 52 -N 59 (VSV8) in the context of a class I MHC K b molecule (15) . We then examined the effects on thymocytes of the in vivo administration of cognate VSV8 peptide ligand by three-color FACS analysis (anti-CD4, -CD8 and -TCR). As expected, Fig. 1 . Agonist but not antagonist peptides induce deletion of DP TCR low thymocytes in N15tg mice in vivo. Mice were injected i.v. with PBS (control) or 24 µg of the indicated peptides. After 24 h thymocytes were triple stained with mAb recognizing CD4, CD8 and the N15 TCR β chain (R53), and analyzed on a FACScan as explained in Methods. In this experiment, 13 and 13.5% of the DP thymocytes remained in the thymus after VSV8 or the agonist peptide (I4) injection respectively, while the antagonist peptide (K1) had no effect on the thymocyte profile. The N15 TCR expression levels in the gated DP (thick line) versus SP (thin line) populations were compared (second column). Note that after VSV8 or I4 injection the residual DP population shows the same high TCR expression as the SP cells. In VSV8-and I4-injected mice, we recovered 4-6 ϫ 10 6 thymocytes, and in control and K1-injected animals, we recovered 3-6 ϫ 10 7 thymocytes.
in the absence of VSV8, thymocytes from this H-2 b strain differentiate from the CD4 -CD8 -double-negative (DN) stage through the CD4 ϩ CD8 ϩ DP stage into mature CD8 ϩ SP thymocytes. All TCR-bearing thymocytes from this strain express the N15 TCR as demonstrated by FACS analysis with the anti-V β clonotypic mAb R53 (Fig. 1) (15) . Consistent with our earlier studies, parenteral i.v. injection of N15tg mice with 24 µg of the cognate peptide, VSV8, caused massive depletion of the DP thymocytes within 24 h (Fig. 1) (15) . Hence the percentage of DP thymocytes in control versus VSV8-treated N15tg mice is reduced from 84 to 13%. Noteworthy is the reproducible observation that all residual DP thymocytes are TCR high . Therefore, in VSV8-injected mice, the TCR level in thymocytes is equivalent on the DP and SP thymocyte subpopulations (Fig. 1, right column) , whereas, in
mice were injected with 24 µg VSV8, and 24 h later the thymocytes were triple stained with the mAb PE-anti-CD4, Red613-anti-CD8 and R53 followed by FITC-conjugated goat antirat IgG as explained in Fig. 1 . Unlike N15 ϩ/ϩ RAG-2 -/-β 2 M ϩ/ϩ , VSV8 injection into N15 ϩ/ϩ RAG-2 -/-β 2 M -/-affects neither the DP population nor the thymocyte FACS profile of the VSV8-injected mice as compared to control PBS-injected animals. Note that all DP thymocytes express low levels of the N15 TCR in N15 ϩ/ϩ RAG-2 -/-β 2 M -/-mice. contrast, the TCR expression level is quite different on the DP and SP thymic subsets in control animals.
Agonistic but not antagonistic altered peptide ligands mediate negative selection Variant peptides closely related in sequence to the cognate antigen, termed altered peptide ligands (APL), can have strikingly different functional effects on T cell activation (i.e. mediating agonistic, antagonistic or no effects) (22, 23) . Analyses of the influence of such peptides, particularly antagonistic APL, on thymic development have yielded controversial results. For example, Page et al. demonstrated using a class II-restricted TCR transgenic mouse model (AD10) that coculture of AD10 thymocytes with antagonist peptide loaded antigen-presenting cells causes a depletion of the DP cells (24) . Hogquist et al., on the other hand, showed that antagonist peptides induce positive selection when added to FTOC of a class I-restricted TCR transgenic mouse, OVA-tcr (25) . Whether these seemingly conflicting findings are a consequence of differences between thymocytes expressing class I-versus class II-restricted TCR or due to differences in the experimental procedures utilized is unknown.
To directly compare the in vivo effect of APL on thymocyte subpopulations, N15tg mice were injected i.v. with identical amounts of VSV8, K1 or I4 peptides. The K1 peptide differs from VSV8 by replacement of a lysine with an arginine at the p1 position. In antigen-induced activation assays of peripheral Fig. 3 . FACS separation analysis of DP thymocyte subpopulations. Mice were injected i.v. with 24 µg of VSV8 and were sacrificed 3 h later. Thymocytes were double stained with R53 mAb followed by FITC-conjugated goat anti-rat IgG and PE-anti-CD4 mAb. The first row shows the thymocyte profile before sorting (CD4 versus CD8 and CD4 versus TCR). Thymocytes were then sorted twice: after the first sort for CD4, the CD4-expressing cells were resorted for CD4 ϩ and TCR low (R1) or CD4 ϩ TCR high (R2; second row). Thymocytes were then stained with anti-CD4 and anti-CD8, and examined by three-color analysis with results presented on CD4, R53 or CD4, CD8 dot plots in the middle and bottom rows respectively. Note the difference in the CD8 expression level between the two DP sorted populations (see text for more details).
N15tg CD8 ϩ SP T lymphocytes, K1 functions to antagonize the cognate VSV8 peptide in both proliferation and cytotoxic assays ((15) and data not shown). In contrast, I4, which differs from VSV8 at the p4 position where there is a replacement of a valine by an isoleucine, functions as an agonist to stimulate antigen-specific T cell activation (15) and data not shown). As shown in Fig. 1 , the agonistic I4 peptide, like VSV8, induces depletion of the majority of DP thymocytes, while leaving intact the numerically minor DP TCR high subset. In contrast, the K1 antagonistic peptide is without any effect as judged by the three-color analysis. Hence, neither the percentage of individual thymocyte subsets nor TCR expression levels are altered relative to the control treated animals. Furthermore, in the VSV8-and I4-injected mice the total number of thymocytes decreased from 3-6 ϫ 10 7 to 2-4 ϫ 10 6 cells while the number of thymocytes remaining after K1 injection was indistinguishable from the controls. Collectively, the in vivo analysis shows that unlike agonist peptides, the antagonist peptide does not deplete the DP thymocyte subset.
To determine whether the K b restriction element is essential for this deletion process, the N15tg/RAG-2 -/-(H-2 b ) mice were bred into a β 2 M -/-background and the outcome of VSV8 injection determined. In β 2 M -/-mice, surface K b expression is completely lost while D b expression is greatly reduced but not eliminated (26) . As shown in Fig. 2 , three-color FACS analysis of N15tg ϩ/ϩ RAG-2 -/-β 2 M -/-mice (control) readily identifies a major DP thymocyte population but no CD8 ϩ SP thymocytes. More importantly, although all the DP thymocytes express low levels of the N15 TCR, they are not depleted upon injection with the VSV8 peptide. In contrast massive depletion of the DP TCR low thymocytes is readily apparent in equivalently treated N15 ϩ/ϩ RAG-2 -/-β 2 M ϩ/ϩ mice (Fig. 2) . These results demonstrate that the depletion of N15 DP TCR low thymocytes is strictly dependent on the H-2K b class I molecule as well as the cognate peptide, VSV8. Moreover, this finding excludes the possibility that the VSV8 peptide per se mediates a non-specific toxic effect responsible for DP TCR low thymocyte deletion. Taken together, these data suggest that in a positively selecting background DP TCR low thymocytes are depleted when exposed to agonist peptides but only when presented by the appropriate class I molecule. In contrast, DP thymocytes which express high TCR levels (DP TCR high ) are resistant to peptide-induced apoptosis even in animals with a positively selecting background ((15 and Fig. 1 ).
Isolation of DP TCR high and DP TCR low subsets
The up-regulation of TCR expression is thought to occur during maturation of DP thymocytes prior to differentiation into SP thymocytes (27) (28) (29) (30) (31) . While most DP thymocytes from normal mice and human (32) express low TCR levels, a very small subpopulation expresses high TCR levels. These TCR high DP cells are believed to have already undergone positive selection (reviewed in 31). Consistent with this view, it has been found that in TCR transgenic mice, including N15tg mice, a much greater fraction of DP cells expresses high TCR levels, but only when the appropriate positively selecting MHC is present (33, 34) . We previously showed that the DP TCR high population in N15tg mice which survives the antigenic peptide injection differentiated into SP thymocytes in vitro and in vivo. Thus by sorting for such residual DP TCR high thymocytes, injecting them intrathymically into β RAG-2 -/-(H-2 b ) mice and following their fate, we observed that DP TCR high thymocytes do not undergo programmed cell death when exposed to peptide antigen. Rather, upon transfer into recipient mice, they are able to mature in vivo into fully functional CD8 ϩ SP T cells which are exported to the peripheral T cell compartment (15) . We assume that these thymocytes have already been positively selected by an as yet unknown endogenous peptide antigen prior to VSV8 injection. We further speculate that such positive selection renders the DP TCR high cells refractory to undergo subsequent negative selection (15) .
Recently, we were able to link caspase activity to antigentriggered deletion of DP fetal and adult thymocytes. Using peptide-based enzyme substrates we showed that TCR ligation by peptide-MHC activates a caspase in DP thymocytes which then causes cell death (16) . If the activation of a thymic caspase upon TCR ligation is the mechanism by which negative selection operates, then the DP TCR high thymocytes, which survive antigen-induced apoptosis, may not activate Fig. 4 . Cytochemical analysis of thymic caspase expression in thymocytes. Thymocytes from PBS-injected (control) N15tg mice (A) or from N15tg mice sacrificed 3 h after VSV8 injection (B-D) were double stained with anti-CD4 and R53 mAb, and were then sorted for the DP TCR low or DP TCR high subpopulations as explained in Fig. 3 . Thymocytes were then transferred by cytospin to microscope slides and the active caspase was detected using the biotin-DEVDamk peptide as described in Methods. Photomicrographs of the staining results of total thymocytes from PBS-injected (A) or VSV8-injected N15tg (B) and DP TCR low thymocytes (C) or DP TCR high thymocytes (D) sorted from VSV8-injected mice are shown using a ϫ40 objective (final magnification is ϫ400).
the thymic caspase upon similar TCR engagement with K b / VSV8. To explore the molecular barrier which allows DP TCR high thymocytes to escape negative selection, we examined whether the caspase is activated in DP TCR low but not in DP TCR high thymocytes after VSV8 injection. Thymocytes were isolated from N15tg mice 3 h after VSV8 administration, and subsequently stained with anti-CD4 and R53 mAb. We chose to isolate the thymocytes 3 h post VSV8 injection since in previous experiments we found that the majority of the DP cells are still viable at this time although the thymic caspase is activated in these thymocytes (16) . In addition, this is within the time frame of selection by antigen in the thymus and does not involve peripheral effects (35) . To obtain a sufficient level of purity, cells were sorted twice. In the first sort cells were gated on CD4 ϩ thymocytes in order to isolate the DP thymocytes (note that in N15tg on a RAG-2 -/-background DP thymocytes are the only cells which express CD4 since CD4 SP lymphocytes do not differentiate in those animals). Subsequently, the CD4 ϩ thymocytes were sorted again by gating on CD4 ϩ (DP) TCR low (70% of DP with the lowest TCR expression) or TCR high (5% of DP with the highest TCR expression). After sorting, a fraction of the sorted thymocytes was restained with the mAb CD4, CD8 and R53. As shown in Fig. 3 (middle row) , the reanalyzed DP TCR low population contains Ͼ91% TCR low thymocytes while the DP TCR high population contains 93% TCR high . Interestingly, although DP TCR high and DP TCR low subpopulations express equivalent CD4 levels, the sorted DP TCR high cells show a reduced level of the CD8 co-receptor (Fig. 3, last row) . The observation that T cells may pass through a CD8 low stage between the CD4 ϩ CD8 ϩ DP stage and the CD8 ϩ SP mature stage has been reported by others. Moreover, intrathymic transfer studies and in vitro analysis of co-receptor re-expression after proteolytic removal of surface co-receptors showed that CD4 ϩ CD8 low cells contain precursors of CD8 ϩ cells and that downmodulation of CD8 may be a component of the thymocytes natural positive selection process (38) (39) (40) (41) . Together these data support the idea that the sorted DP TCR high population represents already positively selected thymocytes.
Active caspase is found in DP TCR low but not DP TCR high thymocytes after cognate peptide administration in vivo
The caspase inhibitor zVADfmk blocks negative selection in FTOC (16) . By incubating thymic sections with biotinDEVDamk, a specific substrate for cysteine proteases, activated caspase could be localized to DP thymocytes within the thymic cortex of fetal and adult N15tg mice after VSV8 treatment (16) . We conclude that the deletion of DP thymocytes occurs through antigen-stimulated activation of a cysteine protease. To test whether activated caspase exists in DP TCR low and DP TCR high thymocytes, we isolated these subpopulations of the DP cells (Fig. 3) 3 h after VSV8 injection. Unsorted thymocytes from PBS-injected and VSV8-injected N15tg animals as well as sorted DP TCR low and DP TCR high cells from VSV8-injected N15tg were transferred to glass slides and analyzed for biotin-DEVDamk binding as described by Clayton et al. (16) . Figure 4(A) , shows the analysis of control thymocytes from a PBS-injected animal which are clearly unreactive with biotin-DEVDamk. In contrast, the majority of the thymocytes from the VSV8-injected animals contain an active caspase(s) as judged by the positive staining (Fig. 4B) . More interestingly, only the sorted DP TCR low thymocytes from the treated animals are stained with biotin-DEVDamk (Fig. 4C ) while almost none of the DP TCR high thymocytes from the same animals have active caspase (Fig. 4D ). The few reactive cells most likely represent the contaminating 6% DP TCR low thymocytes in the DP TCR high preparation (Fig. 3) . These data strongly indicate that the basic mechanism by which DP TCR high thymocytes escape peptide-MHC triggered death involves a lack of induced caspase activity.
Implications
In this report we demonstrate using the N15 TCRtg RAG-2 -/-H-2 b mice that the post-selection DP TCR high thymocytes which are resistant to deletion by peptide antigen do not contain an active caspase. On the other hand, DP TCR low thymocytes obtained from the same VSV8-treated animal express activated caspase leading to cell death. This finding fits well with our assumption that the DP TCR high cells have already been positively selected by as yet unknown endogenous peptides (15) . One possible explanation for the absence of the activated caspase may be that the caspase mRNA is expressed only at a limited stage of development and that the mature DP TCR high thymocytes no longer express the caspase gene. The fact that AP-1 transcriptional and DNAbinding activities required for IL-2 production cannot be induced in the DP TCR low thymocytes but are induced in the DP TCR high subpopulation supports this differential RNA expression theory (42) . Alternatively, the DP TCR high thymocytes may express the caspase but the caspase activity may be inhibited in these cells. For example, the DP TCR high thymocytes may express a CrmA-like or c-IAP-like molecule which interacts directly with the active caspase and inhibits its catalytic activity (43) (44) (45) (46) or FLIP-like proteins which prevent cell death induced by tumor necrosis factor receptor family members by interfering with the apoptosis-signaling pathway. The latter may be of particular importance since FLIP L which contains a caspase-like domain containing tyrosine rather than cysteine in the active center is expressed during the early stage of T cell activation but disappears when T cells become susceptible to Fas ligand-mediated apoptosis (47) . It is also possible that DP TCR high thymocytes express an antagonist decoy receptor similar to that demonstrated recently for TRIL/Apo2L (48, 49) . Such a decoy receptor might block negative selection if a second signal is necessary for thymocyte deletion. Although a requirement for a second signal in the activation of the thymic caspase remains to be determined, there is precedent for the role of dual signaling within the T cell lineage. Activation of resting peripheral T cells requires TCR cross-linking as well as co-stimulation through CD28 and its ligands, B7-1 and/or B7-2, as reviewed in (50) . Apoptosis of peripheral T cells involves second signals through Fas (CD95) and Fas ligand, the expression of which are regulated by TCR signaling (51) . Such dual signaling may also play a role in thymic selection: a second signal derived from thymic stroma along with the specificity-determining TCR-peptide-MHC interaction may be required for negative selection (52) (53) (54) (55) (56) (57) . This signaling component may be absent in the DP TCR high thymocytes or blocked by a decoy receptor. Once the genetic and biochemical details of the negative selection pathway are defined, it should be possible to determine which of these mechanisms account for caspase inactivation and consequently the escape of the DP TCR high thymocytes from peptide-MHC-induced death.
